SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-062994
Filing Date
2013-08-13
Accepted
2013-08-13 08:30:44
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-16281_110q.htm 10-Q 997363
2 EX-31.1 a13-16281_1ex31d1.htm EX-31.1 9770
3 EX-31.2 a13-16281_1ex31d2.htm EX-31.2 9783
4 EX-32.1 a13-16281_1ex32d1.htm EX-32.1 6281
5 EX-32.2 a13-16281_1ex32d2.htm EX-32.2 6258
  Complete submission text file 0001104659-13-062994.txt   8394359

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptct-20130630.xml EX-101.INS 708120
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20130630.xsd EX-101.SCH 54280
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20130630_cal.xml EX-101.CAL 46789
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20130630_def.xml EX-101.DEF 324154
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ptct-20130630_lab.xml EX-101.LAB 974437
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20130630_pre.xml EX-101.PRE 502312
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 131031335
SIC: 2834 Pharmaceutical Preparations